BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38042186)

  • 1. PPARβ/δ-ANGPTL4 axis mediates the promotion of mono-2-ethylhexyl phthalic acid on MYCN-amplified neuroblastoma development.
    Liu Y; Hamid N; Manzoor R; Zhang BF; Liao YL; Wang JX; Pei DS
    Sci Total Environ; 2024 Feb; 912():168949. PubMed ID: 38042186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mono(2-ethylhexyl)phthalate and mono-n-butyl phthalate activation of peroxisome proliferator activated-receptors alpha and gamma in breast.
    Venkata NG; Robinson JA; Cabot PJ; Davis B; Monteith GR; Roberts-Thomson SJ
    Toxicol Lett; 2006 Jun; 163(3):224-34. PubMed ID: 16326050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin-like 4 regulates epidermal differentiation.
    Pal M; Tan MJ; Huang RL; Goh YY; Wang XL; Tang MB; Tan NS
    PLoS One; 2011; 6(9):e25377. PubMed ID: 21966511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
    Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
    Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress.
    Georgiadi A; Lichtenstein L; Degenhardt T; Boekschoten MV; van Bilsen M; Desvergne B; Müller M; Kersten S
    Circ Res; 2010 Jun; 106(11):1712-21. PubMed ID: 20378851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes.
    Robciuc MR; Skrobuk P; Anisimov A; Olkkonen VM; Alitalo K; Eckel RH; Koistinen HA; Jauhiainen M; Ehnholm C
    PLoS One; 2012; 7(10):e46212. PubMed ID: 23056264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion.
    Adhikary T; Brandt DT; Kaddatz K; Stockert J; Naruhn S; Meissner W; Finkernagel F; Obert J; Lieber S; Scharfe M; Jarek M; Toth PM; Scheer F; Diederich WE; Reinartz S; Grosse R; Müller-Brüsselbach S; Müller R
    Oncogene; 2013 Oct; 32(44):5241-52. PubMed ID: 23208498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.
    Lapinskas PJ; Brown S; Leesnitzer LM; Blanchard S; Swanson C; Cattley RC; Corton JC
    Toxicology; 2005 Feb; 207(1):149-63. PubMed ID: 15590130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.
    Foreman JE; Sharma AK; Amin S; Gonzalez FJ; Peters JM
    Cancer Lett; 2010 Feb; 288(2):219-25. PubMed ID: 19660859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiolic acid activates the expression of the PPARβ/δ target genes in MDA-MB-231 cells.
    Hirao-Suzuki M; Takayuki K; Takiguchi M; Peters JM; Takeda S
    Arch Biochem Biophys; 2022 Nov; 731():109428. PubMed ID: 36228705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine disruption: In silico perspectives of interactions of di-(2-ethylhexyl)phthalate and its five major metabolites with progesterone receptor.
    Sheikh IA; Abu-Elmagd M; Turki RF; Damanhouri GA; Beg MA; Al-Qahtani M
    BMC Struct Biol; 2016 Sep; 16(Suppl 1):16. PubMed ID: 27719669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
    Yao PL; Chen L; Dobrzański TP; Zhu B; Kang BH; Müller R; Gonzalez FJ; Peters JM
    Mol Carcinog; 2017 May; 56(5):1472-1483. PubMed ID: 27996177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of di(2-ethylhexyl) phthalate (DEHP) and mono-(2-ethylhexyl) phthalate (MEHP) in rats: in vivo and in vitro dose and time dependency of metabolism.
    Lhuguenot JC; Mitchell AM; Milner G; Lock EA; Elcombe CR
    Toxicol Appl Pharmacol; 1985 Aug; 80(1):11-22. PubMed ID: 4024100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical-genetic interaction landscape of mono-(2-ethylhexyl)-phthalate using chemogenomic profiling in yeast.
    Alfatah M; Wong JH; Kong KW; Utama F; Hoon S; Arumugam P
    Chemosphere; 2019 Aug; 228():219-231. PubMed ID: 31029968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
    Palkar PS; Borland MG; Naruhn S; Ferry CH; Lee C; Sk UH; Sharma AK; Amin S; Murray IA; Anderson CR; Perdew GH; Gonzalez FJ; Müller R; Peters JM
    Mol Pharmacol; 2010 Sep; 78(3):419-30. PubMed ID: 20516370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peroxisome proliferator-activated receptor beta/delta induces lung cancer growth via peroxisome proliferator-activated receptor coactivator gamma-1alpha.
    Han S; Ritzenthaler JD; Sun X; Zheng Y; Roman J
    Am J Respir Cell Mol Biol; 2009 Mar; 40(3):325-31. PubMed ID: 18776129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.
    Girroir EE; Hollingshead HE; Billin AN; Willson TM; Robertson GP; Sharma AK; Amin S; Gonzalez FJ; Peters JM
    Toxicology; 2008 Jan; 243(1-2):236-43. PubMed ID: 18054822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional profiling identifies functional interactions of TGF β and PPAR β/δ signaling: synergistic induction of ANGPTL4 transcription.
    Kaddatz K; Adhikary T; Finkernagel F; Meissner W; Müller-Brüsselbach S; Müller R
    J Biol Chem; 2010 Sep; 285(38):29469-79. PubMed ID: 20595396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders.
    Palomer X; Barroso E; Pizarro-Delgado J; Peña L; Botteri G; Zarei M; Aguilar D; Montori-Grau M; Vázquez-Carrera M
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29558390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose mono(2-ethylhexyl) phthalate promotes ovarian cancer development through PPARα-dependent PI3K/Akt/NF-κB pathway.
    Leng J; Li H; Niu Y; Chen K; Yuan X; Chen H; Fu Z; Zhang L; Wang F; Chen C; Héroux P; Yang J; Zhu X; Lu W; Xia D; Wu Y
    Sci Total Environ; 2021 Oct; 790():147990. PubMed ID: 34380243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.